Catalent
CTLT
#1799
Rank
S$14.64 B
Marketcap
S$80.68
Share price
0.00%
Change (1 day)
5.70%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): S-$8.53

According to Catalent's latest financial reports the company's current EPS (TTM) is S-$8.05. In 2023 the company made an earnings per share (EPS) of S-$8.64 a decrease over its 2022 EPS that were of S$2.89.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$8.53-1.32%
2023S-$8.64-399.56%
2022S$2.89-30.58%
2021S$4.1679.67%
2020S$2.31114.12%
2019S$1.08-15%
2018S$1.2775.44%
2017S$0.72-22.97%
2016S$0.94-59.56%
2015S$2.33282.05%
2014S$0.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
S-$0.42-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
S-$7.58-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
S-$0.95-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
S-$1.88-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA